EHC

Encompass Health Corp

$106.99 +0.53 (+0.50%) At close · Jul 6

Market Cap

$10.98B

99,199,080

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$5.94B +10.5%

FY2025

Net Income

$566.2M +24.2%

FY2025

Operating Margin

12.41% -1.5pp

FY2022

Diluted EPS

$5.54 +24.2%

FY2025

Operating Cash Flow

$1.18B +17.2%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008
Revenue	+10.9%	+10.7%	—	$6.07B	$5.94B	$5.37B	$4.8B	$4.35B	$4.01B	$3.57B	$4.61B	$4.28B	$3.91B	$3.64B	—	—	—	—	—	—	—	—
General & Administrative	+15.2%	+9.3%	+5.9%	$242.1M	$236.2M	$209.2M	$201.7M	$154.3M	$169.5M	$151.6M	$247M	$220.2M	$171.7M	$133.4M	$133.3M	$124.8M	$119.1M	$117.9M	$110.5M	$106.2M	$104.5M	$105.5M
Amortization of Intangibles	-0.6%	-3.0%	-2.4%	—	$28.3M	$28.8M	$32.5M	$28.8M	$31.2M	$32.9M	$58.4M	$51.4M	$49.3M	$48.5M	$36M	$20.3M	$17.3M	$13.4M	$15.2M	$12.9M	—	—
Depreciation & Amortization	+10.4%	+10.1%	+8.9%	$336M	$327.9M	$299.6M	$273.9M	$243.6M	$219.6M	$203M	$218.7M	$199.7M	$183.8M	$172.6M	$139.7M	$107.7M	$94.7M	$82.5M	$78.8M	$73.1M	$67.6M	$82.4M
Total Costs & Expenses	+9.5%	+9.9%	+6.6%	$4.98B	$4.88B	$4.51B	$4.07B	$3.72B	$3.36B	$3.04B	$3.91B	$3.65B	$3.26B	$2.99B	$2.57B	$1.91B	$1.76B	$1.72B	$1.62B	$1.53B	$1.5B	$1.42B
Operating Income	-4.1%	-1.4%	—	—	—	—	—	$539.5M	$559.6M	$563.9M	$612.1M	$555.2M	$578.3M	$588.1M	$485.7M	—	—	—	—	—	—	—
Operating Margin	—	—	—	—	—	—	—	12.41%	13.94%	15.81%	13.29%	12.98%	14.78%	16.15%	—	—	—	—	—	—	—	—
EBITDA	-2.0%	+0.5%	—	—	—	—	—	$783.1M	$779.2M	$766.9M	$830.8M	$754.9M	$762.1M	$760.7M	$625.4M	—	—	—	—	—	—	—
Interest Expense	-11.2%	-7.7%	-1.5%	$123.2M	$123.2M	$137.4M	$143.5M	$175.7M	$164.3M	$183.7M	$159.7M	$147.3M	$154.4M	$172.1M	$142.9M	$109.2M	—	—	—	—	—	—
Other Non-Operating Income	—	+17.5%	+13.1%	$35M	$18.8M	$20.1M	$15.7M	-$5.2M	$7.5M	$8.4M	$30.5M	$2.2M	$4.1M	$2.9M	$5.5M	$31.2M	$4.5M	$8.5M	$2.7M	$4.3M	$3.3M	—
Equity in Earnings of Unconsolidated Entities	+14.0%	+8.2%	-6.8%	$3.8M	$4.3M	$3M	$3.2M	$2.9M	$3.4M	$2.9M	$6.7M	$8.7M	$8M	$9.8M	$8.7M	$10.7M	$11.2M	$12.7M	$12M	$10.1M	$4.6M	$10.6M
Pretax Income	+28.3%	+22.0%	+9.2%	$1B	$953M	$749.6M	$607.2M	$450.8M	$505M	$352.9M	$562.3M	$493.2M	$496.4M	$482M	$395.6M	$386.9M	$395.2M	$340M	$242.9M	$189.9M	$107.5M	—
Income Tax	+24.4%	+20.9%	+3.1%	$207.7M	$192.9M	$150.2M	$132.2M	$100.1M	$101.9M	$74.7M	$115.9M	$118.9M	$145.8M	$163.9M	$141.9M	$110.7M	$12.7M	$108.6M	$37.1M	-$740.8M	-$2.9M	-$70.1M
Net Income	+27.8%	+14.8%	+12.0%	$609.2M	$566.2M	$455.7M	$352M	$271M	$412.2M	$284.2M	$358.7M	$292.3M	$271.1M	$247.6M	$183.1M	$222M	$323.6M	$185M	$208.7M	$899M	$94.8M	$252.4M
Net Margin	—	—	—	—	9.54%	8.48%	7.33%	6.23%	10.27%	7.97%	7.79%	6.83%	6.93%	6.8%	—	—	—	—	—	—	—	—
Net Income Attributable to Noncontrolling Interests	+26.7%	+17.9%	+10.7%	$201.6M	$192.9M	$140.9M	$111M	$94.9M	$105M	$84.6M	$87.1M	$83.1M	$79.1M	$70.5M	$69.7M	$59.7M	$57.8M	$50.9M	$45.9M	$40.8M	$34M	$29.4M
Net Income Available to Common Stockholders	+27.9%	+14.8%	+12.0%	$607.6M	$564.7M	$452.9M	$349.6M	$269.8M	$410.4M	$283.2M	—	—	$256.3M	$247.6M	$181.5M	$215.7M	$231M	$160.3M	$182.7M	$873M	$68.8M	$226.4M
Comprehensive Income	+27.9%	+14.8%	+12.0%	$609M	$566.7M	$455.7M	$352M	$271M	$412.2M	$284.2M	$358.7M	$292.3M	$271M	$247.6M	$182.4M	$221.6M	$322.1M	$186.6M	$208M	$899.5M	$98M	$250M
EPS (Basic) USD/shares	+27.4%	+14.4%	+13.3%	—	$5.62	$4.53	$3.51	$2.72	$4.15	$2.87	$2.90	$2.37	$2.29	$2.20	$1.61	$1.96	$2.05	$1.33	$1.52	$7.40	$0.61	$2.15
EPS (Diluted) USD/shares	+27.1%	+14.2%	+13.8%	—	$5.54	$4.46	$3.47	$2.70	$4.11	$2.85	$2.87	$2.33	$2.26	$2.06	$1.52	$1.82	$2.05	$1.33	$1.56	$6.59	$0.61	$2.08
Shares Outstanding (Basic Avg) shares	+0.4%	+0.4%	-1.1%	—	100.5M	99.9M	99.5M	99.2M	99M	98.6M	123.19M	123.06M	117.78M	112M	112.38M	109.11M	110.74M	118.91M	117.28M	116.65M	111.62M	104.33M
Shares Outstanding (Diluted Avg) shares	+0.6%	+0.5%	-2.1%	—	102.2M	102.2M	101.3M	100.4M	100.2M	99.8M	124.95M	125.45M	124.82M	125.07M	126.96M	126.58M	128.34M	135.88M	137.26M	136.38M	129.85M	121.17M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2011–FY2025: $667.3M in buybacks, $1.06B in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

Compare industry multiples

EV/Revenue

—

EV/EBIT

—

P/E (TTM)

18.48×

Medical Care Facilities median 16.80×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Inpatient Rehabilitation	—	—	—	—	$4,348,600,000	$4,801,200,000	$5,373,200,000	$5,935,200,000
Home Healthand Hospice Segment	$931,100,000	$1,092,000,000	$1,078,200,000	$1,106,600,000	—	—	—	—
Inpatient Rehabilitation Segment	$3,346,200,000	$3,513,000,000	$3,566,200,000	$4,015,000,000	—	—	—	—

By Product & Service (USD)

Component	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Inpatient	$4,251,600,000	$4,693,800,000	$5,230,500,000	$5,756,300,000
Other	—	$107,400,000	$142,700,000	$178,900,000
Outpatient and Other	$97,000,000	—	—	—

Key facts CIK 785161 CUSIP 29261A100 13F (30d) 15 filings 14 filers Visit website Investor relations